Drugs / shRNA-modified CD34+ cells
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03517631 | Feb 2018 → Dec 2020 | AIDS | Shanghai Public Health Clinical Center | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | shRNA-modified CD34+ cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03517631 ↗ |
| Modality | Cell therapy | “Infusion of CD34+ cells transduced with shRNAs.” NCT03517631 ↗ |
| Target | CCR5 | “target CCR5 and HIV genome” NCT03517631 ↗ |